|
US5916588A
(en)
*
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US6090406A
(en)
*
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US4885172A
(en)
*
|
1985-06-26 |
1989-12-05 |
The Liposome Company, Inc. |
Composition for targeting, storing and loading of liposomes
|
|
US5171578A
(en)
*
|
1985-06-26 |
1992-12-15 |
The Liposome Company, Inc. |
Composition for targeting, storing and loading of liposomes
|
|
US5252263A
(en)
*
|
1986-06-16 |
1993-10-12 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
|
US5204112A
(en)
*
|
1986-06-16 |
1993-04-20 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
|
EP0274219A3
(en)
*
|
1986-12-04 |
1988-08-03 |
Takeda Chemical Industries, Ltd. |
Interleukin-2-containing liposome composition and method for the production thereof
|
|
US4963297A
(en)
*
|
1987-12-22 |
1990-10-16 |
The Liposome Company, Inc. |
Spontaneous vesticulation of multilamellar liposomes
|
|
WO1988007852A1
(en)
*
|
1987-04-06 |
1988-10-20 |
Innovative Therapeutics Corporation |
Liposome entrapped magnesium
|
|
US5830498A
(en)
*
|
1987-10-16 |
1998-11-03 |
Board Of Regents, The University Of Texas System |
Liposomal-polyene preliposomal powder and method for its preparation
|
|
US5178875A
(en)
*
|
1991-01-14 |
1993-01-12 |
The Board Of Regents, The University Of Texas System |
Liposomal-polyene preliposomal powder and method for its preparation
|
|
US4950432A
(en)
*
|
1987-10-16 |
1990-08-21 |
Board Of Regents, The University Of Texas System |
Polyene microlide pre-liposomal powders
|
|
JPH03502574A
(ja)
*
|
1987-12-03 |
1991-06-13 |
ザ リポソーム カンパニー,インコーポレイテッド |
メチルセルロース製薬学的組成物
|
|
ATE118348T1
(de)
*
|
1987-12-04 |
1995-03-15 |
Liposome Co Inc |
Liposome hoher stabilität und verfahren zur herstellung und verwendung.
|
|
JPH03501732A
(ja)
*
|
1987-12-22 |
1991-04-18 |
ザ リポソーム カンパニー,インコーポレイテッド |
多重ラメラリポソームの自発的小胞化方法
|
|
US4921644A
(en)
*
|
1988-02-29 |
1990-05-01 |
Technology Unlimited, Inc. |
Mucin directed lipsome
|
|
FR2638639A1
(fr)
*
|
1988-11-08 |
1990-05-11 |
Parincos Parfumerie Cosmet Int |
Composition et procede d'obtention de liposomes oligolamellaires en vue d'une application en cosmetologie et dermatologie topique
|
|
ATE135200T1
(de)
*
|
1989-05-17 |
1996-03-15 |
Res Corp Technologies Inc |
Verfahren und zusammensetzung zur thrombosebehandlung beim säugetier
|
|
US5227170A
(en)
*
|
1989-06-22 |
1993-07-13 |
Vestar, Inc. |
Encapsulation process
|
|
JP2880800B2
(ja)
*
|
1989-06-22 |
1999-04-12 |
ネクスター・フアーマシユーテイカルズ・インコーポレイテツド |
カプセル化方法
|
|
US5290563A
(en)
*
|
1989-07-27 |
1994-03-01 |
Laboratoire Des Stallergenes |
Method for combining a mixture of heterogeneous substances with liposomes
|
|
US5246707A
(en)
*
|
1990-04-26 |
1993-09-21 |
Haynes Duncan H |
Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
|
|
US5091188A
(en)
*
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
FR2677248B1
(fr)
*
|
1991-06-04 |
1995-06-16 |
Lvmh Rech Gie |
Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant un extrait de brunelle.
|
|
US5665381A
(en)
*
|
1992-02-25 |
1997-09-09 |
Nexstar Pharmaceuticals, Inc. |
Inhibition of aggregation of drug containing particles
|
|
WO1994012155A1
(en)
*
|
1992-12-02 |
1994-06-09 |
Vestar, Inc. |
Antibiotic formulation and process
|
|
US5958449A
(en)
*
|
1992-12-02 |
1999-09-28 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for bacterial infections
|
|
US5759571A
(en)
*
|
1993-05-11 |
1998-06-02 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for drug resistant infections
|
|
GB9320668D0
(en)
|
1993-10-07 |
1993-11-24 |
Secr Defence |
Liposomes containing particulare materials
|
|
US5501859A
(en)
*
|
1994-03-22 |
1996-03-26 |
Walter T. Woods, Jr. |
Absorbable magnesium composition and method of using same
|
|
US5756122A
(en)
*
|
1995-06-07 |
1998-05-26 |
Georgetown University |
Liposomally encapsulated nucleic acids having high entrapment efficiencies, method of manufacturer and use thereof for transfection of targeted cells
|
|
US5738868A
(en)
*
|
1995-07-18 |
1998-04-14 |
Lipogenics Ltd. |
Liposome compositions and kits therefor
|
|
ATE386506T1
(de)
|
1995-10-17 |
2008-03-15 |
Jagotec Ag |
Verabreichung unlöslicher arzneistoffe
|
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
|
WO1998046632A2
(de)
*
|
1997-04-11 |
1998-10-22 |
Wilex Biotechnology Gmbh |
Inhibitoren für den urokinaserezeptor
|
|
DE69908304T2
(de)
*
|
1998-02-11 |
2004-02-19 |
Rtp Pharma Corp. |
Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
KR100635456B1
(ko)
|
1998-05-29 |
2006-10-18 |
스키에파마 캐나다 인코포레이티드 |
열보호화 마이크로입자 조성물 및 그의 말단의 스팀멸균방법
|
|
DE69912441T2
(de)
|
1998-08-19 |
2004-08-19 |
Skyepharma Canada Inc., Verdun |
Injizierbare wässerige propofoldispersionen
|
|
IL143197A0
(en)
|
1998-11-20 |
2002-04-21 |
Rtp Pharma Inc |
Dispersible phospholipid stabilized microparticles
|
|
AU7984200A
(en)
*
|
1999-09-21 |
2001-04-24 |
Skyepharma Canada Inc. |
Surface modified particulate compositions of biologically active substances
|
|
US7381421B2
(en)
*
|
1999-12-13 |
2008-06-03 |
Lipoxen Technologies Limited |
Liposomes
|
|
EP1276465B1
(en)
|
2000-04-20 |
2014-03-12 |
Jagotec AG |
Improved water-insoluble drug particle process
|
|
WO2001082892A2
(de)
*
|
2000-05-02 |
2001-11-08 |
Pharmacept Gmbh |
Wirkstoffhaltige liposome
|
|
JP4969761B2
(ja)
|
2000-08-31 |
2012-07-04 |
オバン・エナジー・リミテッド |
所望粒度を持つ固体基材の小粒子および第一材料の小粒状物を含む相乗作用性混合物を製造する方法
|
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
|
NZ527408A
(en)
*
|
2001-02-22 |
2005-04-29 |
Skyepharma Canada Inc |
Hydroxymethylglutarylcoenzyme A (HMG CoA) reductase inhibitor (or a statin) and a fibrate in a single effective oral dosage form to treat dyslipidaemia and dyslipoproteinaemia
|
|
AU2002311617A1
(en)
*
|
2001-06-25 |
2003-01-08 |
The Regents Of The University Of California |
Method for preparation of vesicles loaded with immunostimulatory oligodeoxynucleotides
|
|
US20040018237A1
(en)
*
|
2002-05-31 |
2004-01-29 |
Perricone Nicholas V. |
Topical drug delivery using phosphatidylcholine
|
|
FI120642B
(fi)
|
2007-10-19 |
2010-01-15 |
Biomed Oy |
Mikrokapseloidut liposomikoostumukset
|
|
US20100260830A1
(en)
*
|
2009-04-08 |
2010-10-14 |
Brian A Salvatore |
Liposomal Formulations of Tocopheryl Amides
|
|
CA2922002A1
(en)
|
2013-09-13 |
2015-03-19 |
Arbor Therapeutics, LLC |
Nanoparticulate compositions for targeted delivery of lipophilic drugs and acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
|